Aim of the working group on the Asian perspectives on cancer control: Asian perspective on prostate cancer prevention

Japanese Journal of Clinical Oncology

Volumn 40, Issue SUPPL. 1, 2010, Pages

  Akaza, Hideyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cancer prevention; Prostate cancer

Indexed keywords

ANDROSTANOLONE; DAIDZEIN; DUTASTERIDE; EQUOL; FINASTERIDE; GENISTEIN; PLACEBO;

ARTICLE; ASIA; CANCER CONTROL; CLINICAL TRIAL; FOOD INTAKE; HUMAN; PROSTATE CANCER; SOYBEAN; MALE; PROSTATIC NEOPLASMS; RESEARCH;

ASIA; HUMANS; MALE; PROSTATIC NEOPLASMS; RESEARCH;

EID: 77957272193     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyq120     Document Type: Article

References (5)

1. Crawford ED, Andriole GL, Marberger M, Rittmaster RS. Reduction in the risk of prostate cancer: future directions after the Prostate Cancer Prevention Trial. Urology 2010;75:502-9.
2. Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med 2010;362:1192-202.
3. Tsuji H, Moriyama K, Nomoto K, Miyanaga N, Akaza H. Isolation and characterization of the equol-producing bacterium Slackia sp. strain NATTS. Arch Microbiol 2010;192:279-87.
4. Tanaka M, Fujimoto K, Chihara Y, Torimoto K, Yoneda T, Tanaka N, et al. Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers. Prostate Cancer Prostatic Dis 2009;12:247-52.
5. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, et al. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 2004;34:86-9.